Cytoplasm with Electrostatic Fluidized Bed

Indications for use drugs: widespread breast cancer in postmenopausal women, early stage breast cancer (adjuvant) in postmenopausal women with a positive test result in sensitivity to estrogen, which can not use tamoxifen because of the high risk of thromboembolism or endometrial abnormalities. Method of production of drugs: Table., Coated tablets, 5.2 mg to number 30 in blisters. Pharmacotherapeutic group: L02BG04 - Hormone antagonists and similar facilities. Indications for use drugs: common forms of breast cancer in women post menopause, estrogen localized forms of breast cancer (preoperative therapy) in postmenopausal women with subsequent orhanzberihayuchoyi conducting operations in cases where previously no such operation was considered as shown. Method of production of drugs: Table., Coated tablets, 1 mg № 28. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Contraindications to the use of drugs: late reproductive age, pregnancy, lactation, severe renal disorders (creatinine clearance <20 ml / min), hepatic failure, hypersensitivity to the drug. № 3. Enzyme inhibitors. The main effect of pharmaco-therapeutic effects of drugs: a powerful and highly selective inhibitor of aromatase, the enzyme that is involved in transformation in peripheral tissues here androstendionu estron; indirect labour further converted to estradiol, circulating estradiol reduction shows therapeutic effect in women with breast cancer. L02BG06 - enzyme inhibitors. Contraindications Intracerebral Hemorrhage the use of drugs: hypersensitivity to the drug, domenopauznyy period, significant renal impairment (creatinine clearance <10 ml / min), pregnancy, lactation, children under 16.